切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - PD-1/PD-L1 interaction - Sulfonylurea receptors - Ca2 /calmodulin-dependent protein kinases (CaMKs) - EGFR

34件产品中的 1-10

页面
每页
清除全部
  1. PD-1/PD-L1 inhibitor 2
    B6023 PD-1/PD-L1 inhibitor 2
    Target: PD-1/PD-L1 interaction
    Summary: PD-1/PD-L1相互作用的抑制剂
      ≥42 mg/mL
      insoluble in H2O
  2. EGF816
    B5889 EGF816
     2 Citation
    中文名: 那扎替尼
    Target: EGFR
    Summary: EGFR突变选择性抑制剂
      Soluble in DMSO
  3. AZ5104
    B5836 AZ5104
    Target: EGFR
    Summary: EGFR抑制剂
      ≥16.95 mg/mL
      insoluble in H2O
  4. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM激酶II抑制剂
      ≥29.95 mg/mL
      ≥20.7 mg/mL
  5. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  6. Autocamtide-2-related inhibitory peptide
    B6831 Autocamtide-2-related inhibitory peptide
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: 钙调蛋白依赖性蛋白激酶II(CaM激酶II,CaMKII)抑制剂
      ≥40.2 mg/mL
      ≥45.7 mg/mL
  7. Tolbutamide
    B2194 Tolbutamide
    中文名: 甲苯磺丁脲
    Target: cAMP|Sulfonylurea receptors
    Summary: 第一代钾通道阻滞剂
      ≥10.05 mg/mL
      insoluble in H2O
  8. AZD-9291
    B1104 AZD-9291
     1 Citation
    中文名: 奥希替尼
    Target: EGFR
    Summary: 突变型EGFR抑制剂。
      ≥24.98 mg/mL
      insoluble in H2O
  9. KN-93 hydrochloride
    B1306 KN-93 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMK II抑制剂
      ≥26.9 mg/mL
      ≥5.51 mg/mL
  10. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O

34件产品中的 1-10

页面
每页